PMV Pharmaceuticals Inc

Research PMV Pharmaceuticals Inc (PMVP) on Bullrun: market cap USD 68.80M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerPMVP
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 68.80M
• Financial periodFY2025
• Net income-USD 77.74M
• Free cash flow-USD 73.61M

Valuation Snapshot

latest market cap is USD 68.80M.

About PMV Pharmaceuticals Inc

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc.

Frequently asked questions

What is PMV Pharmaceuticals Inc's market cap?

PMV Pharmaceuticals Inc's market capitalization is USD 68.80M.

What does PMV Pharmaceuticals Inc do?

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States.